About PROCEPT BioRobotics
PROCEPT BioRobotics is a company based in Redwood City (United States) founded in 2009. PROCEPT BioRobotics has raised $348.84 million across 8 funding rounds from investors including Fidelity Investments, T. Rowe Price and Perceptive Advisors. The company has 756 employees as of December 31, 2024. PROCEPT BioRobotics offers products and services including Aquablation Therapy, HYDROS Robotic System, and AquaBeam Robotic System. PROCEPT BioRobotics operates in a competitive market with competitors including Intuitive, Auris Health, Brainlab, Corindus Vascular Robotics and Mazor Robotics, among others.
- Headquarter Redwood City, United States
- Employees 756 as on 31 Dec, 2024
- Stage Public
-
Sectors
HealthcareIndustrial Goods & Manufacturing
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Procept Biorobotics Corporation
-
Annual Revenue
$224.5 M (USD)64.84as on Dec 31, 2024
-
Net Profit
-$91.41 M (USD)13.68as on Dec 31, 2024
-
EBITDA
-$91.38 M (USD)13.27as on Dec 31, 2024
-
Total Equity Funding
$348.84 M (USD)
in 8 rounds
-
Latest Funding Round
$172.5 M (USD), Post-IPO
Sep 06, 2023
-
Investors
Fidelity Investments
& 5 more
-
Employee Count
756
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PROCEPT BioRobotics
PROCEPT BioRobotics is a publicly listed company on the NASDAQ with ticker symbol PRCT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of PROCEPT BioRobotics
PROCEPT BioRobotics offers a comprehensive portfolio of products and services, including Aquablation Therapy, HYDROS Robotic System, and AquaBeam Robotic System.
Ultrasound-guided robotic treatment for benign prostatic hyperplasia.
AI-powered platform for precise BPH therapy procedures.
Waterjet-based system for prostate tissue resection.
People of PROCEPT BioRobotics
Unlock access to complete
Unlock access to complete
Sales and Marketing
94 people
Software Development Team
69 people
Senior Team
26 people
Product Management Team
19 people
Leadership Team
18 people
Associate Team
10 people
Operations Team
10 people
Human Resources and Administration
9 people
Unlock access to complete
Funding Insights of PROCEPT BioRobotics
PROCEPT BioRobotics has successfully raised a total of $348.84M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $172.5 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PROCEPT BioRobotics
PROCEPT BioRobotics has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, T. Rowe Price and Perceptive Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private investment firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Health-tech companies are targeted for venture capital investments.
|
Locked | Locked | Locked | |
|
Private equity and venture capital fund focused on the healthcare sector
|
Locked | Locked | Locked |
Investor details for PROCEPT BioRobotics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PROCEPT BioRobotics
Investment portfolio details for PROCEPT BioRobotics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PROCEPT BioRobotics
Detailed financials for PROCEPT BioRobotics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Procept Biorobotics Comparisons
Peer comparison for PROCEPT BioRobotics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PROCEPT BioRobotics
PROCEPT BioRobotics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Intuitive, Auris Health, Brainlab, Corindus Vascular Robotics and Mazor Robotics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Robotic-assisted surgical systems are developed for minimally invasive procedures.
|
|
| Locked | Locked | Locked |
Robotic microsurgical systems for endoscopy are developed.
|
|
| Locked | Locked | Locked |
Software and integrated solutions for surgical and radiotherapy applications
|
|
| Locked | Locked | Locked |
Remote robotic systems for vascular interventional procedures are developed.
|
|
| Locked | Locked | Locked |
Robotic guidance systems for spine surgery are manufactured and utilized.
|
Detailed competitors of PROCEPT BioRobotics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Procept Biorobotics
Complete news archive for PROCEPT BioRobotics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PROCEPT BioRobotics
PROCEPT BioRobotics was founded in 2009 and raised its 1st funding round 4 years after it was founded.
PROCEPT BioRobotics is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Reza Zadno is the current CEO of PROCEPT BioRobotics.
PROCEPT BioRobotics is a funded company, having raised a total of $348.84M across 8 funding rounds to date.
As of Dec 31, 2024, the latest employee count at PROCEPT BioRobotics is 756.
Annual revenue of PROCEPT BioRobotics is $224.5M as on Dec 31, 2024.
PROCEPT BioRobotics was founded in 2009 in Redwood City, United States, within the medical device sector focused on urology. An image-guided robotic platform is developed for treating benign prostatic hyperplasia through targeted prostate tissue resection. Real-time ultrasonic guidance is utilized for surgical planning and controlled delivery of high-velocity saline streams, enabling personalized procedures in outpatient settings.
PROCEPT BioRobotics's top competitors include Brainlab, Auris Health and Medical Microinstruments.
PROCEPT BioRobotics offers Aquablation Therapy, HYDROS Robotic System, and AquaBeam Robotic System.
Yes, PROCEPT BioRobotics is publicly traded on NASDAQ under the ticker symbol PRCT.
PROCEPT BioRobotics has 6 investors. Key investors include Fidelity Investments, T. Rowe Price, Perceptive Advisors, Computer Programs Marketing Group, and Viking Global Investors.
The ticker symbol of PROCEPT BioRobotics is PRCT on NASDAQ.